首页> 外文期刊>European journal of pain : >Opioid-induced or pain relief-reduced symptoms in advanced cancer patients?
【24h】

Opioid-induced or pain relief-reduced symptoms in advanced cancer patients?

机译:阿片类药物引起或减轻疼痛的症状在晚期癌症患者中?

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: While opioids in increasing doses may produce adverse effects, the same adverse effects may be associated with poor pain control. Moreover, in the clinical setting symptomatic treatment and illness may balance the outcome of opioid titration. Some adverse effects may tend to disappear continuing the treatment in a long-term period. AIMS: The aim of this study was to monitor the effects of a rapid opioid titration combined with symptomatic treatment in patients with poor relief and to monitor these changes in the following period of 20 days. METHODS: A consecutive sample of 35 patients admitted to an acute Pain Relief and Palliative Care Unit were titrated with opioids, according to a department policy, allowing administration of parenteral opioids to assist opioid titration with oral or transdermal opioids. RESULTS: Thirty-three patients were followed up for the period of the study. Pain was adequately controlled and doses were opioid doses were stable after a mean of 40 h. Opioid escalation index (OEI) was extremely high initially, and then progressively declined at the following study intervals. Weakness and nausea and vomiting did not change, as well as confusion and appetite. Drowsiness, constipation and dry mouth significantly increased and then did not change, although a significant decrease in drowsiness was subsequently observed. Well-being improved some weeks after opioid stabilization. In multivariate analysis, drowsiness and dry mouth were correlated to opioid doses. CONCLUSION: The effects reported were often due to multiple causes. A rapid decrease in pain intensity induced by rapid opioid titration does not produce changes in weakness, nausea and vomiting, appetite. While constipation appears the most relevant problem, resistant to common symptomatic treatment, drowsiness initially produced by acute opioid dose increase and the achievement of pain relief, tends to spontaneously decrease, probably as the result of late tolerance. Improved well-being may be the late positive effect of pain relief, also influenced by the setting of home care.
机译:背景:虽然增加剂量的阿片类药物可能产生不良反应,但同样的不良反应可能与不良的疼痛控制有关。此外,在临床环境中,对症治疗和疾病可能会平衡阿片类药物滴定的结果。长期持续治疗可能会导致一些不良反应消失。目的:本研究的目的是监测快速阿片类药物滴定与对症治疗相结合对缓解程度较差的患者的效果,并在接下来的20天内监测这些变化。方法:根据部门政策,连续35例急性疼痛缓解和姑息治疗病房的患者采用阿片类药物进行滴定,允许肠胃外使用阿片类药物协助口服或经皮阿片类药物进行滴定。结果:在研究期间对33例患者进行了随访。平均40小时后,疼痛得到适当控制,阿片类药物剂量稳定。阿片类药物升级指数(OEI)最初非常高,然后在以下研究间隔中逐渐下降。虚弱,恶心和呕吐没有改变,混乱和食欲也没有改变。睡意,便秘和口干明显增加,然后没有变化,尽管随后观察到睡意明显减少。阿片类药物稳定后几周,幸福感得到改善。在多变量分析中,嗜睡和口干与阿片类药物剂量相关。结论:报道的影响通常是由多种原因引起的。快速阿片类药物滴定引起的疼痛强度快速降低不会导致无力,恶心和呕吐,食欲的变化。便秘似乎是最相关的问题,对常见的对症治疗有抵抗力,最初因急性阿片类药物剂量引起的嗜睡和疼痛缓解的发生往往是自发减少的,这可能是由于晚期耐受所致。改善幸福感可能是缓解疼痛的后期积极作用,也受到家庭护理环境的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号